Factors Associated With Cognitive Skills in Patients With Fibromyalgia
Identifying Factors Associated With Cognitive Skills in Female Patients With Fibromyalgia
1 other identifier
observational
41
1 country
1
Brief Summary
The aim of this study was to identify factors associated with cognitive skills in female patients with fibromyalgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 12, 2026
CompletedFirst Submitted
Initial submission to the registry
June 17, 2026
CompletedFirst Posted
Study publicly available on registry
June 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 12, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 12, 2027
June 23, 2026
June 1, 2026
1.3 years
June 17, 2026
June 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Dynamic Loewenstein Occupational Therapy Cognitive Assessment (DLOTCA)
DLOTCA assesses the basic cognitive skills of individuals aged 18-69 years using 28 subtests across 7 cognitive domains (Awareness, Orientation, Spatial Perception, Visual Perception, Visual-Motor Structuring, Application, and Thinking Processes) (13). Each subtest has 3 scoring stages: First stage: Pre-mediation scoring (1 point indicates the worst performance). Second stage: Mediation score (a high score (4 or 5) indicates poor performance). Third stage: Post-mediation scoring (1 point indicates the worst performance).
At baseline (Day 1)
Secondary Outcomes (7)
Fibromyalgia Impact Questionnaire
At Baseline (Day 1)
Pressure Pain Threshold Measurements
At baseline (Day 1)
Cognitive Exercise Therapy Approach Scale
At baseline (Day 1)
Tampa Kinesiophobia Scale
At Baseline (Day 1)
Pain Catastrophizing Scale:
At baseline (Day 1)
- +2 more secondary outcomes
Eligibility Criteria
At least 41 female fibromyalgia patients aged 18-65 years who are followed by Pamukkale University Rheumatology Clinic, diagnosed according to the 2011 American Rheumatology Association Fibromyalgia classification criteria, and who meet the inclusion criteria will be included in the study.
You may qualify if:
- Being between 18-65 years of age
- Being female
- Having been diagnosed with fibromyalgia for at least 6 months, with the appearance of a range of somatic and cognitive symptoms in addition to widespread pain.
You may not qualify if:
- Having another illness that affects their physical condition
- Having cognitive impairment to the extent that they cannot cooperate
- Being pregnant
- Impaired Turkish language comprehension or speech
- Concurrent autoimmune or inflammatory disease
- Diseases affecting the central nervous system (e.g., multiple sclerosis, Parkinson's disease)
- Serious psychiatric conditions that prevent participation (e.g., psychotic disorders).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zülal TATARlead
Study Sites (1)
Pamukkale University
Denizli, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
June 17, 2026
First Posted
June 23, 2026
Study Start
May 12, 2026
Primary Completion (Estimated)
August 12, 2027
Study Completion (Estimated)
September 12, 2027
Last Updated
June 23, 2026
Record last verified: 2026-06